PLK1 and non-small cell lung carcinoma: As results of this effort, we revealed that combination treatment with a USP7 inhibitor and PLK1 inhibitor exerts a strong synergistic effect through down-regulation of MDR1/ABCB1 in taxane-resistant NSCLC cells.